首页> 外文OA文献 >Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma

【2h】

Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma

机译：每周纳米粒子白蛋白绑定 - 紫杉醇与顺铂相对于每周溶剂的紫杉醇加顺铂作为中国晚期食管鳞状细胞癌中的第一线治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Haiying Wang; zhihua yao; hong tang; yan zhao; xiaosan zhang; shuna yao; shujun yang; yanyan liu;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma [J] . Hai-ying Wang, Zhi-hua Yao, Hong Tang, OncoTargets and therapy . 2016,第4期

机译：每周纳米颗粒白蛋白结合紫杉醇联合顺铂与每周溶剂型紫杉醇联合顺铂作为中国晚期食管鳞癌患者的一线治疗
2. Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase Ⅱ open-label clinical study [J] . Shanshan Qin, Jie Qiao, Yu Feng, 中国癌症研究（英文版） . 2019,第002期

机译：每周白蛋白结合紫杉醇/顺铂与吉西他滨/顺铂作为晚期非小细胞肺癌患者的一线治疗：Ⅱ期开放标签临床研究
3. A comparative study of radical radiotherapy with weekly paclitaxel versus radical radiotherapy with weekly cisplatin in the management of locally advanced squamous cell carcinomas of head and neck [J] . Ram Madhavan, Bhaskar P.K, Antonoitte Mary Nithiya, International Journal of Research in Medical Sciences . 2017,第2期

机译：每周紫杉醇根治性放疗与每周顺铂根治性放疗在头颈部局部晚期鳞状细胞癌治疗中的比较研究
4. Effects of Weekly Paclitaxel as a Second-Iine Anticancer Chemotherapy for Patients with Advanced and Recurrent Gastric Carcinoma [C] . Y. Sakurai, I. Yoshida, T. Masui, International Gastric Cancer Congress . 2005

机译：每周紫杉醇作为先进和复发性胃癌患者的二缘抗癌化疗的影响
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma [O] . Hai-ying Wang, Zhi-hua Yao, Hong Tang, 2016

机译：每周纳米颗粒白蛋白结合紫杉醇联合顺铂与每周溶剂基紫杉醇联合顺铂作为中国晚期食管鳞癌患者的一线治疗
7. A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report [O] . Rino, Yasushi, Yukawa, Norio, Murakami, Hitoshi, 2010

机译：S-1单一疗法作为S-1加顺铂作为第二线疗法的一线联合疗法以及每周紫杉醇单一疗法作为三线疗法在晚期胃癌患者中的II期研究：第二篇报告

Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma

著录项

相似文献

相关主题

期刊订阅